3141 results for «710»
3141 results
Leading innovation for patients with valvular heart disease
24 Nov 2024 – From PCR London Valves 2024
Discover the newest advancements in transcatheter heart valves and their role in modern lifetime management of valvular heart disease. Review the latest clinical outcomes demonstrating improved patient care and explore how a diverse device portfolio addresses a wide range of valve anatomies.
Rendez-vous with Myval THV series and Landmark RCT subset analysis
24 Nov 2024 – From PCR London Valves 2024
Discover this interactive session during which the audience learns about and discusses the novel Myval THV Series, a series of valves featuring intermediate and XL sizes. They also discuss the results of the pivotal LANDMARK randomized controlled trial and its relevance in clinical practice.
Optimisation of your valve implantation to ensure lifelong outcomes using a novel self-expanding valve
24 Nov 2024 – From PCR London Valves 2024
Gain insights into the importance of valve optimization post-implantation to secure acute and long-term outcomes. In this session, you will discover the new features and benefits of the ACURATE Prime platform illustrated by a recorded case, and compare how different TAVI platforms perform when treating larger...
Innovation never stops: Cardiovalve in action!
24 Nov 2024 – From PCR London Valves 2024
Join us as we explore the latest advancements in transcatheter tricuspid valve replacement technologies. This session develops the anatomical and imaging challenges associated with this rapidly developing clinical field and provides an update on the Cardiovalve tricuspid clinical program, illustrated by a recorded case.
RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation
25 Nov 2024 – From PCR London Valves 2024
Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...
A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system
25 Nov 2024 – From PCR London Valves 2024
Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...
Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems
25 Nov 2024 – From PCR London Valves 2024
Catch up on this engaging session, featuring a parallel case study of two high-risk patients with severe tricuspid regurgitation. Discover how the PASCAL system is used to treat diverse TR anatomies and explore patient selection and management strategies for the EVOQUE system. Watch a recorded case...
The many faces of complex TAVI
25 Nov 2024 – From PCR London Valves 2024
Learn how to navigate challenging cases illustrating the complexities of TAVI procedures and the importance of device selection and implantation technique. Discover strategies for tackling issues like bicuspid aortic stenosis, difficult access, and complex anatomies.
TAVR implantation techniques: are they the same for all self-expanding TAV platforms?
25 Nov 2024 – From PCR London Valves 2024
Explore the differences between currently available self-expanding TAVI platforms and how they influence device selection and procedural techniques. A panel of experts discuss the pros and cons of these platforms and valuable tips and tricks to tackle various anatomical challenges effectively.
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
25 Nov 2024 – From PCR London Valves 2024
Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...
TAVI innovations: late-breaking trials from PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
What does the future hold for TAVI procedures? Don’t miss the latest innovations—watch this video now! It explores the Late-Breaking Trials from PCR London Valves 2024, featuring groundbreaking studies that could transform the way we approach TAVI in clinical practice.
You’ll dive into the CANNULATE TAVR EXTENDED...
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
Featured research - Tricuspid valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore the latest research on tricuspid valve interventions in this featured session from PCR London Valves 2024. Discover insights on the prognostic impact of heart failure hospitalization in severe tricuspid regurgitation, the influence of moderate mitral regurgitation in tricuspid TEER patients, the association of effective right...
Cinch it if you can - Indirect annuloplasty for functional mitral regurgitation
25 Nov 2024 – From PCR London Valves 2024
This session on mitral regurgitation offers an in-depth look at the EMPOWER trial outcomes, indirect annuloplasty in aFMR, and remodeling with the CARILLON device. Explore the benefits of early treatment for secondary mitral regurgitation, understand the role of left ventricular reverse remodeling, and review the latest...
Featured cases - Strategic approaches in mitral regurgitation
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in this featured session showcasing strategic approaches in the management of mitral regurgitation. Explore a range of complex cases, including percutaneous annuloplasty with a novel device in functional mitral regurgitation, the management of mitral annulus cavity and regurgitation post-healed endocarditis, simultaneous management of two...
Align for the future with the novel balloon expandable Myval transcatheter heart valve series
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore expert insights into best-in-class TAVI practices, from pre-procedural imaging and treatment strategy to procedural tips and post-procedural management. Learn from a compelling case study of an 88-year-old male patient with severe symptomatic aortic stenosis treated with the innovative MyVal Octapro THV....
Featured research - Tricuspid valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
Delve into the latest research on tricuspid valve interventions in this second featured session from PCR London Valves 2024. Gain insights into the characteristics and outcomes of severe isolated tricuspid regurgitation across different treatment strategies, the issue of valve thrombosis after TTVR, the one-year robustness of...
Featured cases - TAVI in bicuspid valve anatomy (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a unique collection of featured TAVI cases in bicuspid valve anatomy. Witness the successful navigation of complex scenarios, including the treatment of severely calcified bicuspid valves, handling of extreme annular dimensions, and the utilization of specialized techniques like antegrade transseptal TAVI. Gain insights that can...
Unlocking the potential of mitral and tricuspid valves clipping
24 Nov 2024 – From PCR London Valves 2024
This session examines two compelling cases: a 78-year-old woman with paroxysmal atrial fibrillation, chest trauma, an osteoporotic sternum fracture, and NYHA II exertional dyspnoea, and an 82-year-old man with chronic three-vessel coronary artery disease, bradycardic AF, peripheral arterial disease, spinal stenosis, and chronic kidney disease. Through...
